C38. Rare and Common Ilds: Epidemiology, Diagnosis, and Management 2022
DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4026
|View full text |Cite
|
Sign up to set email alerts
|

Safety of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Patients with Interstitial Lung Abnormalities or Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…6,7 However, patients with ILAs, especially SF-ILA, are at higher risk of developing ICI-associated pneumonitis (IAP). 8 Our patient had poor pulmonary reserves and IAP might have been fatal. ICI was omitted.…”
Section: Case Reportmentioning
confidence: 70%
“…6,7 However, patients with ILAs, especially SF-ILA, are at higher risk of developing ICI-associated pneumonitis (IAP). 8 Our patient had poor pulmonary reserves and IAP might have been fatal. ICI was omitted.…”
Section: Case Reportmentioning
confidence: 70%